Vaccine

Vaccine

BCG (Bacillus CalmetteGuérin)

DPT (Diptheria, Pertusis, Tetanus)

Purpose

Form

Vaccine against Liquid tuberculosis. The BCG vaccine is 80% effective in preventing tuberculosis for duration of 15 years; however, its protective effect appears to vary according to geography.

Vaccines against three infectious diseases in humans: diphtheria, pertussis (whooping cough) and tetanus

Liquid

Dose

Route of administration

Interval bet. doses 1st dose

.05ml Intradermal



After birth

>right deltoid

.1ml

.5ml

Intradermal

2nd dose

>left deltoid



>vastus lateralis



6weeks/ 1 ½ mos.

2nd dose 

Most people do not experience side effects; side effects are almost always reversible and will go away after therapy is complete.

Before school entrance.

1st dose

Deep intramuscular

Side effects

10 weeks/ 2 ½ mos.

DPT vaccine has been associated with allergic reactions and with encephalopathy, both of which are rare but severe conditions.



redness, irritation, and itching at injection site fever

 

irritability Soreness



3rd dose 14weeks/3 ½

 Hepa B

Vaccine developed for

Liquid

.5ml

Deep intramuscular

mos. 1st dose

(Hepatitis B)

the prevention of hepatitis B virus infection.

>vastus lateralis



6weeks/ 1 ½ mos.

2nd dose 



10 weeks/ 2 ½ mos.

where the shot was given (1 out of 6 children). Loss of appetite (about 1 out of 12 children).

3rd dose 14weeks/3 ½

 Measles

Vaccine developed for prevention of measles.

Liquid

.5l

Subcutaneous >deltoid muscle

mos. 1st dose 

9 mos.

2nd dose 

OPV (Oral Polio Vaccine)

Vaccine developed for prevention of Polio myelitis.

Liquid

2gtts.

Oral >mouth

After 6mos.

1st dose 

6weeks/ 1 ½

  

Fever Mild rash Swelling of glands in the cheeks or neck (rare) If these problems occur, it is usually within 7-12 days after the shot. They occur less often after the second dose.

The vaccine used today has never been known to cause any serious problems, and

mos.

most people don’t have any problems at all with it.

2nd dose 

10 weeks/ 2 ½ mos.

3rd dose Tetanus Toxoid

Tetanus Toxoid is indicated for booster injection only for persons 7 years of age or older against tetanus.

Liquid

.5ml

Intramuscular >deltoid muscle

14weeks/3 ½ mos. TT1 

ASAP

TT2 

1mos. After TT1

TT3 

6mos.afterTT2

TT4 

1yr. after TT3

TT5 

1yr. after TT4

This medication may cause irritation, redness, swelling, warmth, itching, bruising, pain and a hard lump at the injection site which lasts a few days up to a week.